Knight Therapeutics Reports Q1 Revenues Rose 29% to $82.6 Million; Updates 2023 Outlook

Knight Therapeutics Reports Q1 Revenues Rose 29% to $82.6 Million; Updates 2023 Outlook

MT Newswires · 05/11/2023 06:48

Please log in to view news